Panitumumab

Panitumumab

Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).

 

 

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight 147 kDa
CAS No. 339177-26-3

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Cohenuram M, et al.Panitumumab the first fully human monoclonal antibody: from the bench to the clinic. Anticancer Drugs. 2007 Jan;18(1):7-15.

[/accordion]